clinical dose of l carnitine Subgroup analysis by L-carnitine l carnitine dosing protocol cjc

Purifies and revitalises dull skin to a brighter tone

Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man

320 QKI is suppressed in a variety of tumors, and its expression levels are strongly correlated with the aggressiveness, metastatic potential, and clinical outcomes of these tumors

The primary findings of this meta-analysis demonstrated that CHM, whether used as an adjuvant therapy or a stand-alone treatment, enhanced nerve conduction velocity and clinical efficacy during the therapy of PDN and reduced pain scores and TCM syndrome scores

In this study, we identified and characterized the GpoA glutathione peroxidase of S

Lacking the Drug Affinity Complex of the DAC form, it has a short half-life and drives pulsatile, rather than sustained, somatotroph activation, which is why it is studied as a tool for physiological GH pulse dynamics